Term
Sepsis/Meningitis Peds
Early vs Late Onset
|
|
Definition
Early onset: within 1st 5 days of life
Meningitis <10% of cases
Late onset: after 1st week of life
Meningitis >60% |
|
|
Term
CSF Fluid Values
Normal child
(wbc,neutrophils,glucose,protein,rbc) |
|
Definition
- wbc 0-6
- neutrophils 0
- glucose 40-80
- protein 20-30
- rbc 0-2
|
|
|
Term
CSF Fluid Values
Normal infant
(wbc,neutrophils,glucose,protein,rbc)
|
|
Definition
- wbc 0-30
- neutrophils 2-3
- glucose 32-121
- protein 19-149
- rbc 0-2
|
|
|
Term
CSF Fluid Values
Bacterial Meningitis
(wbc,neutrophils,glucose,protein,rbc)
|
|
Definition
- wbc >1000
- neutrophils >50
- glucose <30
- protein >1000
- rbc 0-10
|
|
|
Term
CSF Fluid Values
Viral Meningitis
(wbc,neutrophils,glucose,protein,rbc)
|
|
Definition
- wbc 100-500
- neutrophils <40
- glucose >30
- protein 50-100
- rbc 0-2
|
|
|
Term
Sepsis/Meningitis
Common pathogens
0-1 month |
|
Definition
- group b strep
- E. coli
- Listeria
- Viral
- Coag-neg staph-nosocomial
- Gm neg bacteria (pseudomonas, enterobacter)-nosocomial
- candida
|
|
|
Term
Sepsis/Meningitis
Common pathogens
1-3 month
|
|
Definition
neonatal pathogens:
- group b strep
- E. coli
- Listeria
- Viral
- Coag-neg staph-nosocomial
- Gm neg bacteria (pseudomonas, enterobacter)-nosocomial
- candida
- and
- H. influenzae type b
- Neisseria menigiitidis
- strep pneumoniae
|
|
|
Term
Sepsis/Meningitis
Common pathogens
3 months - 12 years
|
|
Definition
- H. influenzae
- n. meningitidis
- s. pneumoniae
|
|
|
Term
Sepsis/Meningitis
Common pathogens
>12 years
|
|
Definition
- N. meningitidis
- S. pneumoniae
|
|
|
Term
Sepsis/Meningitis
Treatment Regimens
0-1 month |
|
Definition
ampicillin + gent
or
ampicillin +cefotaxime |
|
|
Term
Sepsis/Meningitis
Treatment Regimens
1-3 month
|
|
Definition
ampicillin +cefotaxime-ceftriaxone |
|
|
Term
Sepsis/Meningitis
Treatment Regimens
3 month-12 years
|
|
Definition
ceftriaxone +/- vanco
add vanco based on regional incidence of resistant s. pneumoniae
|
|
|
Term
Sepsis/Meningitis
Treatment Regimens
>12 years
|
|
Definition
ceftriaxone +/- vanco
add vanco based on regional incidence of resistant s. pneumoniae |
|
|
Term
Chemoprophylaxis of Bacterial Meningitis
Why and who? |
|
Definition
- why: To prevent spread of H.influ and N. meningitidis
- who: high risk groups, household contacts, day care centers, direct contact with index patients secretions
|
|
|
Term
Chemoprophylaxis of Bacterial Meningitis
N. meningitidis
Which Drugs?
|
|
Definition
Rifampin po
ceftriaxone im |
|
|
Term
Chemoprophylaxis of Bacterial Meningitis
H. Influ
Which Drugs?
|
|
Definition
|
|
Term
Chemoprophylaxis of Bacterial Meningitis
N. meningitidis
Drug doses per age range (3)
|
|
Definition
</= 1 month: Rifampin 5mg/kg/dose po 12h x2 days
>1 month: 10mg/kg/dose po q12h x2 daysChemoprophylaxis of Bacterial Meningitis
N. meningitidis
Which Drugs?
adults: 600mg po q12h 2 days
Ceftriaxone: <12 125mg im x1
>12 250mg im x1 |
|
|
Term
Chemoprophylaxis of Bacterial Meningitis
H. Influ
Drug doses?
|
|
Definition
Rimampin:
20mg/kg/dose (max 600mg) daily x4 days |
|
|
Term
Contraindications to receiving vaccines
(6) |
|
Definition
Anaphylactic rxn:
a. Neomycin in inactivated polio,mmr varicella
b. egg proteins in influenza, (note mmr grown in chick embryo tissue, egg allergy not a contraindication)
Acute moderate or severe febrile illness
Immunodeficiency with oral polio,mmr and varicella
Pregnancy with mmr, varicella
recent admin of immune globulin : mmr,varicella
Encephalopathy within 7 days after admin of a previous dose of DTap
|
|
|
Term
Misconceptions regarding contraindications to vaccination
(7) |
|
Definition
- Mild acute illness
- current abx therapy
- rxn to DTap involving only soreness, redness or swelling at the site
- pregnancy of the mother of the vaccine recipient
- brestfeeding
- allergies to abx other than neomycin or streptomycin
- family hx of an adverse effect after vaccine admin
|
|
|
Term
Vaccine considerations in special populations:
preterm infants
(3) |
|
Definition
- Immunize on the basis of chronologic age
- do not reduce vaccine doses
- delay HepB because of reduced response until patient 2kg or older than 30 days unless mother is positive
|
|
|
Term
Vaccine considerations in special populations:
Immunocompromised
(2) |
|
Definition
- should not receive live vaccines (mmr,varicella, oral polio,rotavirus)inactivated vaccines & immune globs ok
- household contacts should not receive oral polio, but mmr, influenza, varicella and rotavirus are recommended
|
|
|
Term
Vaccine considerations in special populations:
Receiving corticosteroids
(3)
|
|
Definition
Live vaccines: may admin to pat receiving a. topical steroids
b. physiologic maint doses
c. low or mod doses (<2mg/kg/day of prednisone equiv.)
Immed after high doses (>2mg/kg/day) have been discontinued if on for <14 days
1 month after high doses (>2mg/kg/day)
have been discontinued if on for >14 days |
|
|
Term
Vaccine considerations in special populations:
HIV
(3) |
|
Definition
MMR should be admin unless patient severely immunocompromised
Varicella in asymptomatic or mildly symptomatic patients
Inactivated vacines should be admin routinely
|
|
|
Term
Pediatric seizures
drugs of choice
Partial
|
|
Definition
Valproic acid
carbamazepine
phenytoin |
|
|
Term
Pediatric seizures
drugs of choice
Tonic-Clonic
|
|
Definition
Valproic acid
caramazepine
phenytoin |
|
|
Term
Pediatric seizures
drugs of choice
Myoclonic
|
|
Definition
|
|
Term
Pediatric seizures
drugs of choice
Absence
|
|
Definition
Ethosuximide
valproic acid |
|
|
Term
Pediatric seizures
drugs of choice
Lennox-Gastaut
|
|
Definition
valproic acid
topiramate
lamotrigine |
|
|
Term
Pediatric seizures
drugs of choice
Infantile spasms
|
|
Definition
adrenocorticotropic hormone (ACTH) |
|
|
Term
Pediatric seizures
Alternatives
Partial
|
|
Definition
phenobarb
gabapentin
lamotrigine
tigabine
topiramate
oxcarbazepine
zonismide
levetiracetam |
|
|
Term
Pediatric seizures
Alternatives
Tonic-Clonic
|
|
Definition
lamotrigine
opiramate
zonisamide
levetiracetam |
|
|
Term
Pediatric seizures
Alternatives
Myoclonic
|
|
Definition
Topriamte
zonisamide
levetiracetam
|
|
|
Term
Pediatric seizures
Alternatives
Absence
|
|
Definition
lamotrigine
zonisamide
levetiracetam |
|
|
Term
Pediatric seizures
Alternatives
Lennox-Gastaut
|
|
Definition
|
|
Term
Pediatric seizures
Alternatives
Infantile spasms
|
|
Definition
Vigabatrin
lamotrigine
tiagabine
topiramate
valproic acid
zonisamide |
|
|
Term
Phenobarb
Adverse Effects (4)
&
Pharmacokinetic considerations (2) |
|
Definition
Adverse Effects
Cognitive dysfuction
Sedation
rash
Decreased bone density
Pharmacokinetic
Linear kinetics
decreased effectiveness of oc |
|
|
Term
Phenytoin
Adverse Effects (5)
&
Pharmacokinetic considerations (2)
|
|
Definition
Adverse Effects
rash
gingival hyperplasia
hirsutism
Decreased bone density
Teratogenic
Pharmacokinetic
nonlinear kinetics
decreased effectiveness of oc
|
|
|
Term
Carbamazepine
Adverse Effects (4)
&
Pharmacokinetic considerations (2)
|
|
Definition
Adverse Effects
rash
Hyponatremia
Decreased bone density
Teratogenic
Pharmacokinetic
Autoinduction
decreased effectiveness of oc
|
|
|
Term
Valproic Acid
Adverse Effects (7)
&
Pharmacokinetic considerations (1)
|
|
Definition
Adverse Effects
Weight gain
Menstrual irregularities
polycystic ovarian syndrome
Hyperandrogenism
Hepatotoxicity (most cases in child<2)
Teratogenic
Thrombocytopenia
Pharmacokinetic
cyp inductions > in children
|
|
|
Term
Gabapentin
Adverse Effects (2)
&
Pharmacokinetic considerations (3)
|
|
Definition
Adverse Effects
somnolence
weight gain
Pharmacokinetic
nonlinear kinetics
increased clearance in children <6
dose adjust in renal insuff
Other
minimal drug interactions
minimal cognitive effects
may worsen Lennox-Gastaut
|
|
|
Term
Felbamate
Adverse Effects (4)
&
Pharmacokinetic considerations (1)
|
|
Definition
Adverse Effects
Anorexia, nausea, weight loss
Insomnia, somnolenc
Aplastic anemia (adults > children)
Hepatic failure
Pharmacokinetic
Clearance 50:50 renal/hepatic
|
|
|
Term
Lamaotrigine
Adverse Effects (2)
&
Pharmacokinetic considerations (1)
|
|
Definition
Adverse Effects
Rash (children >adults)
Steven-johnson syndrome
Pharmacokinetic
autoinduction
Other
Minimal Cognitive effects
|
|
|
Term
Topiramate
Adverse Effects (4)
&
Pharmacokinetic considerations (2)
|
|
Definition
Adverse Effects
cognitive dysfunction
weight loss
glaucoma
oligohidrosis (children > adults)
Pharmacokinetic
increased clearance in children
dose adjust in renal insuff
|
|
|
Term
Tiagabine
Adverse Effects (2)
&
Pharmacokinetic considerations (1)
|
|
Definition
Adverse Effects
Dizziness
Nonconvulsive status epilepticus
Pharmacokinetic
clearance 50% increased in children
Other
Minimum cognitive effects
|
|
|
Term
Levetiracetam
Adverse Effects (2)
&
Pharmacokinetic considerations (4)
|
|
Definition
Adverse Effects
Headache
somnolence
Pharmacokinetic
Linear kinetics
Renal excreation
clearance 40% increased in children
no effect on cyp
Other
minimal drug interactions
|
|
|
Term
Oxcarbazepine
Adverse Effects (2)
&
Pharmacokinetic considerations (4)
|
|
Definition
Adverse Effects
Hyponatremia >CBZ
Rash <CBZ
Pharmacokinetic
Linear kinetics
Clearance 40% increased in child <6
Induces CYP3a4
Inhibits CYP2C19
Other
minimum cognitive effects
|
|
|
Term
Zonisamide
Adverse Effects (2)
&
Pharmacokinetic considerations (2)
|
|
Definition
Adverse Effects
Weight loss
Rash
Oligohidrosis
Pharmacokinetic
Linear kinetics
Primarily renal excretion, no effect on cyp
Other
Better tolerated by children than adults
|
|
|
Term
Vigabatrin
Adverse Effects (2)
&
Pharmacokinetic considerations (0)
|
|
Definition
Adverse Effects
Vision loss
Weight gain
Pharmacokinetic
none
Other
only available through restricted distribution
|
|
|
Term
ADHD
Stimulent meds
Methylphenidate
long acting (6) |
|
Definition
Short acting-usually need 2-3 doses daily
Long acting:
Methylphenidate SR/ER
(Ritalin SR, Metadate ER)
duration up to 8hrs, bid dosing for afternoon symptoms usually needed
Methylphenidate OROS
(Concerta)
duration 10-12 hours
Dexmethylphenidate ER
(Focalin XR)
duration approx 8hrs, faster onset than concerta
Methylphenidate modified release
(Metadate CD)
duration 6-8 hrs, may be opened and sprinkled on food
Methylphenidate ER
(Ritalin ER)
Efficacy may wane later in the day
Capsules may be opened and sprinkled on food
Methylphenidate patch
(Daytrana)
apply 2hrs before effect needed,
duration up to 3 hrs after patch off
recommended wear time 9hrs, may to up to 16hrs
*Use with caution in patients with glaucoma, tics, psychosis and MAO inhibitors
|
|
|
Term
ADHD
Stimulant
Amphetamine |
|
Definition
Mixed amphetamine salts (Adderall XR)
Duration 10-12 hrs
may be opened and sprinkled on food
Lisdexamfetamine dimesylate (Vyvanse)
Duration 10 hrs |
|
|
Term
|
Definition
No evidence of causative relationship between stimulants and SCD.
AAP recommends targeted cardiac hx and careful exam before starting.
Routine ECG not recommended unless hx and physical suggest caridac disease |
|
|
Term
ADHD
Non-Stimulant Meds types
|
|
Definition
atomoxetine
antidepressants - not FDA approved
noradrenergic
tricyclics
alpha-adreneric receptor agonists
clonidine - not FDA approved
Guanfacine - FDA approved |
|
|